Det bør bemærkes, at et yderligere behandlingsforløb ikke vurderes at være nødvendigt som rapporteret af indehaverne af markedsføringstilladelserne.
It should be noted that a second course of treatment is not considered necessary as reported by Marketing Authorisation Holders.